The need to reduce the amount of salt in the diet effective, but the efficacy is limited by the size of the population at risk and the intensity of the has remained a very controversial issue in spite of strong evidence from animal experimental and intervention. The public health approach to gradual reduction of available salt in the diet is human studies that increased salt intake is associated with increased blood pressure levels.
T are rapid and predictable in relationship to the changes in salt consumption. There is little evidence of a unique distribution of the responses to salt intake.
In spite of what appears to be overwhelming evidence he association between the amount of salt ( NaCl ) consumed, blood pressure levels, and risk of cardiovascular disease ( CVD ) and other diseases has been known for at least 50 years.
1 Studies by Dahl, 2 Meneely, 3 and others docu-that higher salt intake results in higher blood pressure levels, there remains a continued belief by some that mented the association between estimated population consumption of salt and elevated blood pressure, as salt in the diet is of little importance. The scientists who support this few are unfortunately wrong. Their well as the association between salt intake and blood pressure in animal models, rats. Further ecological vocal opposition to the need to lower the salt consumption of the U.S. population, as well as active opstudies by Page et al 4 documented the high correlation between level of salt intake of the population and position by part of the food industry have slowed a much needed reduction in the amount of salt conprevalence of hypertension. More recent ecological studies 5 have further documented the association of sumed by the U.S. population, as well as that in other countries. Much of the controversy related to the assosalt intake, blood pressure, and stroke mortality rates ( Figure 1 ) .
6 Short-term human experimental feeding ciation of salt intake and blood pressure is due to misinterpretation of the concepts of clinical and prestudies clearly showed that increases or decreases in salt intake resulted in either an increase or decrease ventive medicine and public health. in blood pressure. 7 The effects of change in salt intake
CLINICAL PERSPECTIVE
The clinician can use very effective drugs to treat hypertension. Reduction of salt in the diet results in a reductions in blood pressure are clearly not as great the blood pressure is clearly a major determinant of risk of stroke, other hypertensive complications, and as can be accomplished by relatively small doses of diuretics or other drugs. Furthermore, maintaining atherosclerotic diseases, such as myocardial infarction. The TOMHS study included both drugs and 100 mmol decrease is very hard and even a 50 mmol decrease is difficult given the large amount of added nonpharmacological intervention. Nonpharmacological interventions are probably no substitute for drug salt in the food chain. The clinician therefore presumes that the amount of salt in the diet is of relatively therapy for most hypertensives. However, the combination of nonpharmacological treatments and drugs little importance. In some ways the clinician is correct. The Trial of Mild Hypertension Study ( TOMHS ) 11, 12 may be better than drug therapy alone. The clinicians' observation that nonpharmacological therapy does evaluated both drug therapy and nonpharmacological therapy in a randomized blinded trial. The nonphar-not lower the blood pressure in hypertensives as much as drug therapy, 13 and therefore may not be as macological therapies included exercise, lower salt intake, and weight loss, and was very successfully im-beneficial to the patient may be correct. It is also very difficult to maintain nonpharmacological intervention plemented. However, the nonpharmacological therapy with placebo was not nearly as effective in as compared to taking a pill. This, however, does not mean that lowering the amount of salt in the diet of reducing blood pressure over 48 months, compared to the combination of nonpharmacological therapy and a the population is ineffective. Stopping smoking after the onset of lung cancer or even in the few years prior variety of antihypertensive medications. Furthermore, the participants on drug therapy had lower to the onset of lung cancer is not a very effective intervention. Drug therapy, surgery, and radiation are risks of subsequent CVD and less symptomatology, than those who had a combination of nonpharmaco-clearly more effective in treating lung cancer. Smoking cessation before the development of lung cancer or logical therapy and placebo. The extent of lowering better yet total life time abstinence will substantially especially in the short-term. Sodium was reduced 78 mEq in the urine at 6 months and 51 mEq at 36 reduce the risk of lung cancer, a far more preferable approach than the treatment of lung cancer.
months. The participants, even in the sodium reduction arm, were still consuming around 130 mEq of salt Lipid lowering drugs are more effective than diet alone for lowering LDL cholesterol ( LDLc ) for most or close to 8 g of salt, approximately 2 g above the U.S. recommended levels of salt intake, even after the patients with coronary heart disease ( CHD ) and elevated LDLc. This, however, does not mean that di-intervention at 6 months.
Change in blood pressure was very consistent with etary approaches to lowering LDLc in the population are ineffective. In fact, the reduction of LDLc levels in the effects of reduced salt intake. Compared with the usual care, there was a 2.9 mm decrease in systolic the entire population, through dietary modification, is probably having a bigger overall effect on reduction blood pressure at 6 months, 2 mm at 18 months, and 1.2 mm at 36 months. All were significant, P õ .03 at of CHD than drug therapy for lowering LDLc for those who already had a heart attack or have very 36 months. The study required fairly intensive nutritional and behavioral intervention to reach even these high LDLc.
The claim that reducing salt intake only lowers modest goals of sodium reduction. In TOHP I, 18 the decrease in blood pressure was directly related to the blood pressure a few millimeters and therefore is ineffective compared to drugs, really has no importance amount of reduced sodium in the urine. Similar analysis has not been completed for TOHP II. in evaluating the need to reduce salt consumption for the ''population. '' In TOHP II the salt reduction and weight loss arm, as well as the combined sodium and weight loss, was PREVENTIVE MEDICINE APPROACH associated with a substantial decrease in the incidence of hypertension. 16, 17 At 48 months, the incidence of The preventive medicine, as well as the clinical approaches, assumes that hypertension is a unique dis-hypertension was about 38% in the weight loss, sodium reduction and weight loss, and sodium groups ease. The population can be divided into hypertensives and nonhypertensives. The Fifth Joint National as compared to about 44% cumulative incidence in the usual care, P Å .02 to .06. Similar results for the Committee Report ( JNC V ) 14 has partially modified the traditional classification of hypertension. The pre-prevention of hypertension and reduced sodium intake were noted in the TOHP I study. The results are ventive medicine approach assumes that a unique high risk subpopulation of hypertensives can be iden-impressive and important by clearly documenting the effects that salt reduction does lower blood pressure tified and this subgroup has unique genetic ( host susceptibility ) , and / or environmental exposures includ-in this high risk population. The decrease in blood pressure noted in these studies is fairly consistent ing high salt intake, obesity, heavy alcohol consumption, etc. The goal therefore is to identify the at-risk with the estimated 7 mm decrease in systolic blood pressure for 100 mEq change in sodium, ie, about 3 hypertensives and prevent hypertension and its complications. 15 to 3.5 mm for a 50 mEq decrease versus the 3 mm for a 50 mEq decrease in the TOHP II intervention Specific interventions that are proposed include reduction of salt intake, which can be tailored to this compared to control groups at 6 months.
There are, however, three major problems associhigh risk population. Several of the recent clinical trials in nonhypertensives, but high risk individuals, have ated with the preventive medicine approach. First, the size of the at-risk population is huge. By age 70, 40% focused as one of their goals the prevention of hypertension. 13 In the recently completed phase two of the of the U.S. population is expected to be hypertensive. Second, the intensity of the intervention required for Trial of Hypertension Prevention ( TOHP ) 16 is probably the best example of the prevention trials. The trial any individual is obviously very extensive, and it is hard to believe that there is enough nutritional and randomized 2,382 men and women aged 30 to 54 not taking antihypertensive medication. Diastolic blood behavioral intervention, personnel and resources available to generalize the individual or group appressures for entry to the study were between 83 to 89 mm Hg and systolic pressure õ 140 mm Hg. The study proach for the entire population at risk of hypertension. Even with the high quality personnel such as compared weight loss, weight loss and sodium reduction, and sodium reduction alone, versus a control in TOHP I and II and other intervention studies, the effectiveness of the intervention is modest because of group. The goal was to reduce sodium to less than 80 mmol / day, around 5 g of salt. An initial observation the very high amount of salt in the diet, ie, 10 to 11 g at baseline, and the fact that the majority of salt is in this study was the very high salt intake in the population based on 24 h urines of 188 mEq in the controls in processed food, 70% to 80%. Decreasing the amount of added salt in cooking or in table salt has only a or about 11 g of salt in the diet.
The trial results are similar to those of TOHP I 17 modest effect on salt intake. The third problem is that long-term adherence to a low salt intake is difficult. 
duction may have been lost in TOHP II. In TOHP I 50 to 60 million at-risk individuals. If 30% were salt sensitive, then there would be about 20 million salt the effect of salt reduction was pretty well maintained for 18 months, however, there is relatively little data sensitive individuals. There would therefore be two obvious problems. First the cost of finding all of these about change in salt intake over several years, especially cessation of active intervention. The basic prob-individuals, and second, the difficulties of developing a unique low salt dietary approach for approximately lem is not the effectiveness of the low salt diet in reducing blood pressure, but the efficacy of the appli-20 million people. Clearly, neither approach is feasible. Salt sensitivity is furthermore not an all or nothcation to the large population of individuals at risk.
Several related aspects of the prevention approach ing phenomenon. It is a continuous variable consistent with a variety of host-environmental interactions. need to be considered. First is the concept that only a percentage of this high risk population is ''salt sensi-There are probably a few individuals who are extremely salt sensitive, and probably at the other extive'' and needs to have a lower salt intake. Weinberger et al 19 have described laboratory methods for the mea-treme individuals who are completely not salt sensitive. This is characteristic of the interrelationship besurement of salt sensitivity. The approach is to see the effects on blood pressure, salt excretion and various tween many environmental exposures and the host susceptibility, ie, cholesterol levels, weight, etc. Orbiochemical, physiological parameters of a rapid increase in sodium followed by a rapid decrease the next ganizing a high risk preventive approach for these 20 million salt sensitive individuals is just not feasible. day. A 10 mm decrease in blood pressure between the sodium loading and depletion was considered a posi-Such an approach is similar to trying to identify the 10% of cigarette smokers likely to get lung cancer and tive response and 6 to 9 mm in determinant.
Several studies have suggested that older individu-presuming that the rest of the population could continue to smoke cigarettes. als, blacks, those who have low-renin hypertension, and high sympathetic activity have a greater fre-
The next high risk approach is to identify the specific genes that cause hypertension. Genotyping the quency of salt-sensitive hypertension. 19 In an extensive study of 309 whites and 81 blacks, Luft et al 20 population to identify the susceptible from non-susceptible so that the intervention can be limited to susreported that 32% of blacks and 30% of whites who were normotensive were also salt sensitive, as com-ceptible has great intuitive appeal and has generated a substantial amount of research dollars. Unfortunately, pared with 73% of black and 55% of white hypertensives. Salt sensitivity in both groups were significantly the approach is based on false premises and will fail.
Hypertension is an arbitrarily defined disease. The related to age.
Sullivan et al used a different approach to measure distribution of blood pressure in the population is continuous. There are no genes for hypertension besalt sensitivity. 21 They defined salt sensitivity as a 5% increase in blood pressure from a change in 10 to 200 cause there is no disease hypertension. The search for hypertensive genes is like searching for genes for the mEq of sodium in the diet, holding potassium constant at 60 mEq. They determined that 29% of white ''soul.'' There are many biochemical and physiological determinants of blood pressure levels. The mechaand 50% of black borderline hypertensives were salt sensitive. The distribution of change in blood pressure nistic modelers of hypertension are determined to identify everyone of the pathophysiological determiwas normally distributed. There was no evidence of bimodality or a unique salt sensitive population in nants of blood pressure, and then working with geneticists, to identify the specific genes, ie, polymortheir study. Similarly in the Luft and Weinberger studies, there is little evidence of unique salt sensitive phisms, that contribute to the variations in blood pressure level. It is very likely that the genes, especially individuals. The cutoff points for blood pressure change are arbitrary to define ''salt sensitivity.'' The combinations of genes, will provide a better understanding of the grade of susceptibility to environmenreproducibility of these measures over time is also a major issue. An individual may be salt sensitive at tal exposures, such as salt, 26,27 obesity, alcohol intake, other nutrients, and blood pressure levels. Unique one test, but not 6 months or 1 or 2 years later.
It is very likely that there are individuals more salt genes 28 have been identified, which account for a relatively small percentage of elevated blood pressure in sensitive in terms of an increase in blood pressure than other individuals. It is likely that certain charac-the population. The genetic disorders are important for the understanding of the pathophysiology of hyteristics can define who will be more salt sensitive, including age, black race, low renin, 22 high end tidal pertension, but contribute little to the overall prevalence of hypertension in the population. Similarly, CO 2 23 and mild acidosis, psychosocial stresses, insulin resistance 24, 25 and higher sympathetic activity. 24 within pedigrees, it is probable that specific genetic polymorphisms, as well as environmental exposures, Presume that there really was a unique salt sensitive / 2107$$2245 04-13-97 20:19:17 eajha EL: AJH account for the high familial aggregation of blood pres-based on the observation that salt intake in the population is a continuous distribution and that the majorsure levels. However, it is extremely unlikely that specific ity of the population is consuming more than 4 to 6 genes or several genes will be identified that will make it g of salt per day in the United States. The sources of possible to identify individuals likely to develop elevated salt in the diet are from mainly processed foods, not blood pressure, hypertension, from those that will not. It just from table salt or salt added for cooking. The may be possible to identify high relative risk, but the distribution of blood pressure levels are continuous attributable risk will be extremely small. The search for in the population with some skewing to higher levels. the genes for elevated blood pressure have been remarkThe risk of CVD, especially stroke and CHD is probaably unrewarding to date. 29, 30 It is almost certain, howbly linearly related to the levels of blood pressure, ever, that specific genetic polymorphisms will be identifrom relatively low diastolic and systolic blood presfied that affect blood pressure levels and susceptibility to sure. 31 For example, among the Multiple Risk Factor salt in the diet. However, it is also almost certain that the Intervention Trial ( MRFIT ) screenees the risk ingenetic polymorphisms will not separate the population creases from a systolic blood pressure of around 120 into high and low risk, but rather a continuous distribumm Hg and a diastolic blood pressure õ 80 mm Hg. tion of risk of hypertension. The gene for eating salty
Most of the population is at risk even those considered pretzels is unlikely to be found. at higher risk than the lower levels of blood pressure, PUBLIC HEALTH APPROACH even those considered normotensive. The increased The final model is the public health approach to re-risks have been reported for different ethnic and racial groups and also in other studies for women. The extrapolation of the risk of CHD and stroke 100,000, while treatment for blood pressure for those with a diastolic reading of 95 mm Hg would decrease from observational studies such as the MRFIT screenees have shown that an average 2 mm decrease the events by 214.5 / 100,000.
There is substantial tracking or correlation of blood in blood pressure, equivalent to perhaps a 30 to 40 mEq decrease in salt intake, would reduce CHD mor-pressure from childhood and young adult life into adult life. 35 Thus, prevention of the increase in blood tality by 4%, stroke mortality by 6%, and total mortality by 3%, that is, a reduction of possibly 12,000 deaths pressure over time would have major public health benefit. The public health approach therefore proper year in the 45 to 64 year old age group.
33
A further analysis of the potential reduction in risk poses a shift in the population distribution of blood pressure by preventing the rise in blood pressure with was done by Cook et al, 34 using data from the Framingham Study. They estimated that a 2 mm decrease increasing age through a decrease in sodium in the diet. If 100 mEq decrease of sodium resulted in a 7 in blood pressure over a 2 year period would decrease the number of CHD events per 100,000 population by mm decrease in blood pressure, then reducing salt intake from 10 g, about 171 mEq to 6 g, about 100 45.8 for those who had a blood pressure of 70 to 79 mm Hg, 67 for those with a blood pressure 80 to 89 mEq should reduce blood pressure by about 5 mm and possibly total mortality in the 45 to 64 age group mm Hg, and 33.3 for those with a blood pressure of 90 to 94 mm Hg, and 64.6 for those with a blood pres-of 28,000 per year or about 7% overall.
The success of the public health approach requires sure ¢ 95 mm Hg ( Figure 2 ) . A 2 mm decrease in blood pressure for those with diastolic pressure°a decrease in the amount of salt that is added to processed food and a change in food selection by 
